Synercid (quinupristin-dalfopristin) is now available for emergency use
February 1996
Rhone-Poulenc Rorer's investigational antibiotic Synercid (quinupristin-dalfopristin) is now available for emergency use...for certain resistant gram positive infections.
It's being used for vancomycin-resistant enterococci (VRE)...and methicillin-resistant Staph aureus (MRSA) or Staph epidermidis in patients who can't take vancomycin. It also seems to be active against penicillin-resistant pneumococcus.
Both quinupristin and dalfopristin are in a new class of antibiotics called streptogramins. The combination has synergistic effects. (Hence the name Synercid.)
Get concise advice on drug therapy, plus unlimited access to CE
Pharmacist's Letter Canada includes:
- 12 issues every year, with brief articles about new meds and hot topics
- 300+ CE courses, including the popular CE-in-the-Letter
- Quick reference drug comparison charts
- Access to the entire archive